Market Forecast By Type (Oral, Injection, Other), By Application (Companion Animals, Livestock Animals) And Competitive Landscape
| Product Code: ETC7556425 | Publication Date: Sep 2024 | Updated Date: Feb 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
According to 6Wresearch internal database and industry insights, the India Veterinary Medicine Market is anticipated to grow at a compound annual growth rate (CAGR) of 8.2% during the forecast period (2026–2032).
Below is the evaluation of the year-wise growth rate along with key drivers:
| Years | Estimated Annual Growth (%) | Growth Drivers |
| 2021 | 6.4% | Rising awareness regarding zoonotic diseases and initial focus on livestock health. |
| 2022 | 7.1% | Surge in pet adoption in urban metros and expansion of organized veterinary retail. |
| 2023 | 7.5% | Increased government funding for the National Animal Disease Control Programme. |
| 2024 | 7.9% | Incorporation of digital health monitoring and AI-driven diagnostic tools in clinics. |
| 2025 | 8.1% | Launch of Pashu Aushadhi generic medicine outlets and dairy sector modernization. |
The India Veterinary Medicine Market report thoroughly covers the market by type and application. The report provides a detailed analysis of ongoing market trends, opportunities/high-growth areas, and market drivers that will help stakeholders align strategies based on current and future market dynamics.
| Report Name | India Veterinary Medicine Market |
|---|---|
| Forecast Period | 2026–2032 |
| CAGR | 8.2% |
| Growing Sector | Livestock Animals |
India Veterinary Medicine Market is projected to attain enormous expansion in the coming years on the back of massive transition from basic treatments to advanced preventive healthcare and specialized medicine. Apart from this, the growth is primarily bolstered by the "AtmaNirbhar Bharat" initiative and the Animal Husbandry Infrastructure Development Fund (AHIDF), which has incentivized private investment in vaccine production and cold chain logistics.
On the other hand, the rise of pet humanization in Tier-1 cities is leading to increased medicalization rates for companion animals. For example, the growing preference for high-quality vaccines and chronic care medications is reshaping the market. Besides, the rapid modernization of the dairy and poultry sectors has created high-demand environments for anti-infectives and medicated feed additives, making India a global hub for cost-effective veterinary biologicals.
Below are some prominent drivers and their influence on the market dynamics:
| Drivers | Primary Segments Affected | Why It Matters |
| Livestock Productivity | By Application (Livestock) | Farmers invest in health to ensure higher milk and meat yields for the rising population. |
| Pet Humanization | By Application (Companion) | Urban pet owners consider animals as their beloved family member, increasing spend on premium medicines. |
| Disease Control Hub | By Type (Injection/Other) | Government-led mass vaccination proliferates against FMD and Brucellosis stimulate demand. |
| Digital Integration | By Distribution (Online/Retail) | Tele-veterinary platforms and e-pharmacies increase medicine access in rural areas. |
| Generic Accessibility | By Type (Oral/Injection) | New "Pashu Aushadhi" centers provide affordable generic substitutes to farmers. |
India Veterinary Medicine Market is expected to grow exponentially, reaching a CAGR of 8.2% during the forecast period (2026-2032). Due to increasing pet ownership across the country, escalating livestock farming, government initiatives aimed at disease control and prevention, and the widespread adoption of modern veterinary medicines and diagnostics, the market is set for robust growth in the upcoming years. With technological advancements, the demand for innovative and more effective treatments will further spur the India Veterinary Medicine Market growth.
Below are some major restraints and their influence on the market dynamics:
| Restraints | Primary Segments Affected | What This Means |
| Counterfeit Products | By Type (Oral/Other) | Substandard drugs in rural markets can lead to treatment failure and ad resistance. |
| Shortage of Skilled Vets | By Application (Livestock) | Limited professional presence in remote areas delays the administration of medicine. |
| Price Sensitivity | By Type (Injection) | More and more costs of advanced biologicals can limit adoption among small-scale farmers. |
| Regulatory Delays | By Type (Other/New Drugs) | Complex approval processes for novel molecules can slow down innovation cycles. |
| Cold Chain Gaps | By Type (Injection/Vaccines) | Lack of consistent refrigeration in rural belts affects the efficacy of sensitive products. |
The India Veterinary Medicine Market is expected to continue its upward momentum during the forecast period. However, on the other hand, the presence of counterfeit or substandard veterinary products in unorganized rural markets creates a major threat to animal health. Also, the inadequate infrastructure for cold chain management in certain states remains a major hurdle, as many advanced vaccines and biologics lose effectiveness if not stored at strictly controlled temperatures during the "last-mile" delivery.
A few latest trends shaping the dynamics of India Veterinary Medicine Market:
Investment opportunities in the India Veterinary Medicine Industry are:
Below is a list of prominent companies operating in the India Veterinary Medicine Market:
| Company Name | Indian Immunologicals Ltd. (IIL) |
|---|---|
| Established Year | 1982 |
| Headquarters | Hyderabad, Telangana |
| Official Website | Click Here |
A subsidiary of NDDB, Indian Immunologicals Ltd. is the largest manufacturer of Foot and Mouth Disease (FMD) vaccines in the world and a pioneer in animal health biologicals in India.
| Company Name | Virbac Animal Health India |
|---|---|
| Established Year | 2006 (India Operations) |
| Headquarters | Mumbai, Maharashtra |
| Official Website | Click Here |
Virbac Animal Health India is a global leader focusing on a wide range of products including nutritional supplements, parasiticides, and dermatological treatments for both livestock and pets.
| Company Name | Hester Biosciences Ltd. |
|---|---|
| Established Year | 1987 |
| Headquarters | Ahmedabad, Gujarat |
| Official Website | Click Here |
Hester Biosciences is one of India’s leading animal healthcare companies, specializing in poultry and livestock vaccines and holding a strong presence in the international export market.
| Company Name | Intas Animal Health |
|---|---|
| Established Year | 1999 (Division) |
| Headquarters | Ahmedabad, Gujarat |
| Official Website | Click Here |
A dedicated division of Intas Pharmaceuticals, Intas Animal Health offers a comprehensive portfolio of therapeutic products and has a vast distribution network covering the entire Indian subcontinent.
| Company Name | Zoetis India |
|---|---|
| Established Year | 1952 (as Pfizer Animal Health) |
| Headquarters | Mumbai, Maharashtra |
| Official Website | Click Here |
Zoetis India, the world's largest animal health company, has a strong Indian footprint providing advanced vaccines, medicines, and diagnostic products backed by global R&D.
According to Indian Government Data, they have played a pivotal role through initiatives like the National Animal Disease Control Programme (NADCP), which has an outlay of over INR 13,000 crore to immunize cattle, buffaloes, sheep, goats, and pigs. Apart from this, the Union Budget 2026 has introduced a loan-linked capital subsidy scheme to train 20,000 additional veterinary professionals and establish modern private veterinary hospitals. Besides this, the Pashu Aushadhi component under the revised Livestock Health and Disease Control Programme (LHDCP) aims to provide generic veterinary medicines at affordable rates through specialized kiosks, ensuring that marginal farmers have access to high-quality healthcare.
The India Veterinary Medicine Market is projected to witness stable growth, driven by the expansion of 5G-enabled IoT in livestock monitoring, which will allow for real-time health alerts and automated medication dispensing. The future will see a total convergence of human and animal health under the "One Health" approach, focusing on preventing the spillover of zoonotic infections. As the global demand for antibiotic-free meat rises, the Indian market will likely transition toward standardized biologicals and immune-stimulants, favoring players who invest in sustainable, residue-free health solutions.
The report offers a comprehensive study of the following market segments and their leading categories:
According to Vasudha, Senior Research Analyst, 6Wresearch, the Injection segment is anticipated to lead the India Veterinary Medicine Market share as it remains the preferred route for high-bioavailability and fast-acting treatments in both large animals and emergency companion care. The dominance is further supported by the massive scale of government-led immunization programs where intramuscular and subcutaneous vaccines are administered to millions of livestock annually.
The report offers a comprehensive study of the following market segments:
| 1 Executive Summary |
| 2 Introduction |
| 2.1 Key Highlights of the Report |
| 2.2 Report Description |
| 2.3 Market Scope & Segmentation |
| 2.4 Research Methodology |
| 2.5 Assumptions |
| 3 India Veterinary Medicine Market Overview |
| 3.1 India Country Macro Economic Indicators |
| 3.2 India Veterinary Medicine Market Revenues & Volume, 2022 & 2032F |
| 3.3 India Veterinary Medicine Market - Industry Life Cycle |
| 3.4 India Veterinary Medicine Market - Porter's Five Forces |
| 3.5 India Veterinary Medicine Market Revenues & Volume Share, By Type, 2022 & 2032F |
| 3.6 India Veterinary Medicine Market Revenues & Volume Share, By Application, 2022 & 2032F |
| 4 India Veterinary Medicine Market Dynamics |
| 4.1 Impact Analysis |
| 4.2 Market Drivers |
| 4.2.1 Increasing pet ownership and awareness about animal healthcare |
| 4.2.2 Growing demand for quality livestock products |
| 4.2.3 Technological advancements in veterinary medicine |
| 4.3 Market Restraints |
| 4.3.1 Lack of skilled veterinary professionals |
| 4.3.2 Regulatory challenges in product approvals and licensing |
| 4.3.3 High cost associated with veterinary treatments |
| 5 India Veterinary Medicine Market Trends |
| 6 India Veterinary Medicine Market, By Types |
| 6.1 India Veterinary Medicine Market, By Type |
| 6.1.1 Overview and Analysis |
| 6.1.2 India Veterinary Medicine Market Revenues & Volume, By Type, 2022- 2032F |
| 6.1.3 India Veterinary Medicine Market Revenues & Volume, By Oral, 2022- 2032F |
| 6.1.4 India Veterinary Medicine Market Revenues & Volume, By Injection, 2022- 2032F |
| 6.1.5 India Veterinary Medicine Market Revenues & Volume, By Other, 2022- 2032F |
| 6.2 India Veterinary Medicine Market, By Application |
| 6.2.1 Overview and Analysis |
| 6.2.2 India Veterinary Medicine Market Revenues & Volume, By Companion Animals, 2022- 2032F |
| 6.2.3 India Veterinary Medicine Market Revenues & Volume, By Livestock Animals, 2022- 2032F |
| 7 India Veterinary Medicine Market Import-Export Trade Statistics |
| 7.1 India Veterinary Medicine Market Export to Major Countries |
| 7.2 India Veterinary Medicine Market Imports from Major Countries |
| 8 India Veterinary Medicine Market Key Performance Indicators |
| 8.1 Number of veterinary clinics and hospitals in India |
| 8.2 Adoption rate of advanced veterinary treatments and technologies |
| 8.3 Government investments in veterinary healthcare infrastructure |
| 9 India Veterinary Medicine Market - Opportunity Assessment |
| 9.1 India Veterinary Medicine Market Opportunity Assessment, By Type, 2022 & 2032F |
| 9.2 India Veterinary Medicine Market Opportunity Assessment, By Application, 2022 & 2032F |
| 10 India Veterinary Medicine Market - Competitive Landscape |
| 10.1 India Veterinary Medicine Market Revenue Share, By Companies, 2025 |
| 10.2 India Veterinary Medicine Market Competitive Benchmarking, By Operating and Technical Parameters |
| 11 Company Profiles |
| 12 Recommendations |
| 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here